Type 2 Diabetes

Clinical Case Study: Managing Type 2 Diabetes with coMra Therapy

This case study details the treatment of a 63-year-old female patient presenting with significant fluctuations in blood glucose levels, ranging from 90 to 340 mg/dL throughout the day. These instabilities resulted in constant, severe weakness and malaise. Additionally, the patient reported moderate, dull abdominal pain – specifically in the right hypochondrium and navel area – as well as chronic constipation, with bowel movements occurring only once every three to five days. She also experienced intermittent numbness and paresthesia (a "goosebumps" sensation) in her lower extremities during the morning hours. Upon clinical examination, her fasting blood glucose was recorded at 340 mg/dL.

Patient History and Diagnosis

The patient’s medical history spanned more than 20 years. Her management of the condition had been inconsistent; she did not adhere to a strict diet, frequently adjusted her prescribed medication dosages without medical supervision, and lacked regular clinical monitoring.

Based on the patient’s history, clinical complaints, and physical examination, she was diagnosed with: * Type 2 diabetes (with uncontrolled glycemic levels) * Diabetic sensory neuropathy in the lower extremities * Chronic cholecystitis * Coronary heart disease * Hypertension (noted as being in remission)

The coMra Therapy Intervention

The patient underwent a single course of coMra therapy, consisting of 21 daily treatments. The results following this course were significant:

* Glycemic Stabilization: The patient’s blood glucose levels stabilized, ranging from 125 to 160 mg/dL throughout the day. This eliminated the extreme fluctuations previously observed (90 to 340 mg/dL), demonstrating a marked improvement in glycemic control. * Symptom Resolution: The abdominal pain subsided completely, and bowel function returned to a normal, regular rhythm. * General Well-being: The patient reported a notable improvement in her overall sense of well-being, characterized by a stable mood and a significant boost in daily energy levels.

Recommendations for Ongoing Care

Following the success of this initial course, it was recommended that the patient repeat the same coMra therapy protocol after a two-to-three-week break. Furthermore, it was advised that she continue with maintenance courses at least once per quarter throughout the year to support long-term health and metabolic stability.